Lilly Gets Protein Optimization System In Applied Molecular Evolution Deal

Lilly's acquisition of Applied Molecular Evolution will give the company access to technology for optimizing proteins and genes for specific therapeutic targets

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet